Yüklüyor......
Anti-HCV drugs in the pipeline
Several directly-acting and host-targeting antivirals that inhibit hepatitis C virus replication have entered clinical trials. Amongst the most advanced of these are RG7128, an inhibitor of the NS5B polymerase; BMS-790052, an inhibitor of NS5A; and alisporivir, an inhibitor of human cyclophilins. Th...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3775341/ https://ncbi.nlm.nih.gov/pubmed/22440918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2011.10.019 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|